Answers are grounded in this paper and cite their sources.
Healthy aging is defined not only by the absence of disease but by the capacity to maintain function and to recover from physiological stress. This integrative review proposes and specifies resilience medicine as a framework that moves beyond static descriptions of aging by linking metabolic adaptation to functional recovery across eight interconnected domains: inflammatory regulation, mitochondrial function, metabolic flexibility, musculoskeletal function, vascular regulation, microbiome-associated processes, neurocognitive function, and circadian organization. The framework separates an individual functional profile—baseline function, reserve, stress response, and recovery—from formulation-specific evidence profiles for nutritional and nutraceutical interventions. Representative trials show why this separation matters: contrasting cardiovascular outcomes with different omega-3 formulations, together with studies of muscle function, cognition, and vascular surrogate endpoints, demonstrate that formulation, population, comparator, and outcome determine what an intervention can claim. We introduce the Multi-System Resilience Activity construct and conditional resilience breadth as transparent reporting tools that map evidence across domains while keeping mechanistic, surrogate, functional, and clinical-event findings distinct, and apply them to published trial data. Finally, we define a validation agenda built on standardized challenge–recovery protocols, repeated metabolic measurements, and patient-relevant functional endpoints. Resilience medicine thereby provides a testable pathway from metabolomic discovery to clinically meaningful evidence in healthy aging.
No takes yet. Share an insight, caveat, or question.
Harms et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: